Home > Drug Search >
  • company_query: Abeona Therapeutics
  •   > 
Drug Filter
Category:
chemistry (17) biology (8)
Status:
Approved (1) BLA Filing (1) Phase Ⅲ (2) Phase Ⅱ (10) Phase Ⅰ (11)
Clinical Stage:
Pending (3) Active (12) Discontinued (9)
Bio-Type:
Gene therapy (1) Cell therapy (1) Vaccine (2) Recombinant cytokines (1)
Indication:
Cerebral infarction (1) Colorectal neoplasms (1) Endometrial cancer (1) Epidermolysis bullosa (1) Hypercholesterolemia (1) Hyperlipidemia (1) Lymphoma (1) Melanoma (1) Metastatic breast cancer (1) Obesity (1) Ovarian cancer (1) Overactive bladder (OAB) (1) Prostate cancer (2) Psoriasis (1) Mucopolysaccharidosis III (2) Small cell lung cancer (SCLC) (1) Social withdrawal (1) Solid tumours (3) Type 2 diabetes (1) Head and neck cancer (1) Colorectal cancer (2) Fungal infection (1) Susceptible bacterial infections (1) Biliary cancer (1) Acute ischemic stroke (AIS) (1) Hematological cancer (1) Ischemic stroke (1) Graft versus host disease (1) Metastatic cancer (1) Mesothelioma (1) Liver cancer (1) Thromboembolism (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top